
A New Paradigm in Health Monitoring
SAVA is developing the world's most advanced wearable biosensor, capable of measuring multiple biomarkers — including glucose, lactate, cortisol, and ketones — continuously and in real-time just below the skin. Founded by Imperial College London bioengineers, the company targets chronic condition management and preventative health through seamless, minimally invasive monitoring technology paired with a connected mobile platform.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account